Subcutaneous progesterone versus vaginal progesterone for luteal phase support in in vitro fertilization: A retrospective analysis from daily clinical practice |
Schutt, Marcel
(Department of Gynecological Endocrinology, Reproductive Medicine and Osteoporosis, University Hospital Giessen and Marburg, Philipps University of Marburg)
Nguyen, The Duy (Department of Gynecological Endocrinology, Reproductive Medicine and Osteoporosis, University Hospital Giessen and Marburg, Philipps University of Marburg) Kalff-Suske, Martha (Department of Gynecological Endocrinology, Reproductive Medicine and Osteoporosis, University Hospital Giessen and Marburg, Philipps University of Marburg) Wagner, Uwe (Department of Gynecological Endocrinology, Reproductive Medicine and Osteoporosis, University Hospital Giessen and Marburg, Philipps University of Marburg) Macharey, Georg (Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki) Ziller, Volker (Department of Gynecological Endocrinology, Reproductive Medicine and Osteoporosis, University Hospital Giessen and Marburg, Philipps University of Marburg) |
1 | Fatemi HM. The luteal phase after 3 decades of IVF: what do we know? Reprod Biomed Online 2009;19 Suppl 4:4331. DOI |
2 | Yanushpolsky EH. Luteal phase support in in vitro fertilization. Semin Reprod Med 2015;33:118-27. DOI |
3 | Schwartz E, Bernard L, Ohl J, Bettahar K, Rongieres C, Lichtblau I, et al. Luteal phase progesterone supplementation following induced natural cycle frozen embryo transfer: a retrospective cohort study. J Gynecol Obstet Hum Reprod 2019;48:95-8. DOI |
4 | Doblinger J, Cometti B, Trevisan S, Griesinger G. Subcutaneous progesterone is effective and safe for luteal phase support in IVF: an individual patient data meta-analysis of the phase III trials. PLoS One 2016;11:e0151388. DOI |
5 | Venturella R, Vaiarelli A, Buffo L, D'alessandro P, Colamaria S, Pedri S, et al. Progesterone for preparation of the endometrium for frozen-thawed blastocyst transfer in vitro fertilization cycles: a prospective study on patients' opinions on a new subcutaneous formulation. Gynecol Endocrinol 2018;34:766-71. DOI |
6 | Check JH. Luteal phase support in assisted reproductive technology treatment: focus on Endometrin(R) (progesterone) vaginal insert. Ther Clin Risk Manag 2009;5:403-7. DOI |
7 | Penzias AS. Luteal phase support. Fertil Steril 2002;77:318-23. DOI |
8 | Lockwood G, Griesinger G, Cometti B; 13 European Centers. Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study. Fertil Steril 2014;101:112-9.e3. DOI |
9 | de Ziegler D, Sator M, Binelli D, Leuratti C, Cometti B, Bourgain C, et al. A randomized trial comparing the endometrial effects of daily subcutaneous administration of 25 mg and 50 mg progesterone in aqueous preparation. Fertil Steril 2013;100:860-6. DOI |
10 | van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev 2011;(10):CD009154. |
11 | Vaisbuch E, Leong M, Shoham Z. Progesterone support in IVF: is evidence-based medicine translated to clinical practice? A worldwide web-based survey. Reprod Biomed Online 2012;25:139-45. DOI |
12 | Baker VL, Jones CA, Doody K, Foulk R, Yee B, Adamson GD, et al. A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization. Hum Reprod 2014;29:2212-20. DOI |
13 | van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev 2015;2015:CD009154. |
14 | Supramaniam PR, Mittal M, McVeigh E, Lim LN. The correlation between raised body mass index and assisted reproductive treatment outcomes: a systematic review and meta-analysis of the evidence. Reprod Health 2018;15:34. DOI |
15 | Yavuz A, Demirci O, Sozen H, Uludogan M. Predictive factors influencing pregnancy rates after intrauterine insemination. Iran J Reprod Med 2013;11:227-34. |
16 | Gaskins AJ, Toth TL, Chavarro JE. Prepregnancy nutrition and early pregnancy outcomes. Curr Nutr Rep 2015;4:265-72. DOI |
17 | Child T, Leonard SA, Evans JS, Lass A. Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles. Reprod Biomed Online 2018;36:630-45. DOI |
![]() |